Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Harris

Showing results (1-10 of 682) with videos related to

Pageof 69
Sort By:
Cancer Research|July 1, 1981
1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapyA L Harris
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|November 1, 1985
DNA repair: relationship to drug and radiation resistance, metastasis and growth factorsA L Harris
Advances in Cancer Research|January 1, 1992
p53 expression in human breast cancerA L Harris
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapyA L Harris
Nature|April 4, 1991
Cancer genes. Telling changes of baseA L Harris
British Journal of Clinical Pharmacology|April 1, 1979
The relationship of cytosine arabinoside phosphorylation to inhibition of DNA synthesis in human leukaemic myeloblasts [proceedings]A L Harris
British Journal of Cancer|August 18, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)A L Harris
Lancet (London, England)|May 1, 1997
Antiangiogenesis for cancer therapyA L Harris
Cancer Surveys|January 1, 1985
DNA repair and resistance to chemotherapyA L Harris
Angiogenesis|January 1, 1997
Clinical trials of anti-vascular agent group B Streptococcus toxin (CM101)A L Harris
Pageof 69

Showing results (1-10 of 682) with videos related to

Sort By:
Pageof 69
Cancer Research|July 1, 1981
1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapyA L Harris
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|November 1, 1985
DNA repair: relationship to drug and radiation resistance, metastasis and growth factorsA L Harris
Advances in Cancer Research|January 1, 1992
p53 expression in human breast cancerA L Harris
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapyA L Harris
Nature|April 4, 1991
Cancer genes. Telling changes of baseA L Harris
British Journal of Clinical Pharmacology|April 1, 1979
The relationship of cytosine arabinoside phosphorylation to inhibition of DNA synthesis in human leukaemic myeloblasts [proceedings]A L Harris
British Journal of Cancer|August 18, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)A L Harris
Lancet (London, England)|May 1, 1997
Antiangiogenesis for cancer therapyA L Harris
Cancer Surveys|January 1, 1985
DNA repair and resistance to chemotherapyA L Harris
Angiogenesis|January 1, 1997
Clinical trials of anti-vascular agent group B Streptococcus toxin (CM101)A L Harris
Pageof 69